MYNIPPON: love and life guilt free.  Find out more about lifestyle, relationships, dating, health, fitness, cooking, beauty, fashion, and life.

Lifestyle Vioxx, Bextra recall Personal Finance Plastic surgery Drugs Find a man
-

Links to news on recall of Vioxx and Bextra

February 2005

Note:  Below are the links to articles on Vioxx, Celebrex, and Bextra during the February 2005 period.  Click here for latest news on Vioxx, Celebrex, and Bextra.

Tysabri recall: Another drug that received fast track approval like Vioxx and Celebrex
Vioxx recall controversy heats up in Canada
Vioxx and Bextra recommendations from FDA panel in doubt due to conflicts of interest
Merck shareholder lawsuits consolidated into one MDL to be tried in New Jersey
Louisiana Medicaid restricts prescriptions of Celebrex and Bextra
New Zealand restricts prescription of Cox-2 drugs
Celebrex found to be safe for live cirrhosis patients
Aleve safety affirmed by FDA panel
Making sense of FDA panel recommendations on Vioxx, Celebrex, and Bextra
Implications of FDA's decisions on Vioxx, Celebrex, and Bextra
Merck allowed to resume sale of Vioxx in the United States
Celebrex and Bextra to stay on the market but with a strong warning
European Medicines Agency (EMEA) bans, restricts Cox-2 drugs
Merck wants to sell Vioxx again
Dr. David Graham blasts Merck, Pfizer, and FDA over Cox-2 drugs like Vioxx, Celebrex, and Bextra
Pfizer claims that Celebrex and Bextra are safe drugs
Merck and Pfizer ignored drug safety and focused on profits
Vioxx class action lawsuits to be tried in Louisiana 
Celebrex, Bextra, and other Cox-2 drugs have same risks as Vioxx, Merck argues
Vioxx doubled risk of heart attacks, another study finds
Celebrex, Bextra recall hearings begin
FDA again fails American people by refusing to recall Adderall XR
FDA tries to protect Merck and Pfizer
Merck and Pfizer fought a marketing battle over Vioxx, Celebrex, and Bextra
Australian agency TGA bans or limits prescription of Cox-2 drugs
Celebrex attorneys recruiting plaintiffs as class action lawsuits are filed
Merck could have learned of Vioxx risks earlier, if it had not abandoned a crucial study
Merck knew of Vioxx risks earlier, Wall Street Journal reports
Update on Celebrex, Bextra, Prexige, and Arcoxia
Will Vioxx recall bankrupt Merck?
Pfizer reaffirms Celebrex safety
Vioxx side effects reconfirmed

What do you think?

Copyright.  All rights reserved.